With brilliant storytelling and a talented cast, Apple TV's Pluribus keeps viewers hooked from beginning to end.

Northwestern University research finds educational videos in hospitals improve new fathers’ knowledge of infant care, though retention may fade. Trump may have damaged Reflecting Pool by having ...

During a House Oversight Committee hearing titled "Amnesty and Chaos: Abuse of U.S. Immigration Policy," Representative James Walkinshaw (D-VA) gave his Republican colleagues an example of "chaos" by ...

"The Legend of Vox Machina" Season 4 (Credit: Prime Video) “The Legend of Vox Machina” Season 4 kicks off June’s new arrivals for Amazon’s Prime Video. The latest season of the hit Critical Role ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc.

In a rare direct address, Secretary of State Marco Rubio blamed the former leader Raúl Castro for the country’s longstanding electricity and resource shortages. By Ali Watkins Secretary of State Marco ...

Google is giving the Gemini app a massive update, bringing a bunch of nifty changes. The chatbot phase is fading, and the company now wants Gemini to become something closer to a full-time digital ...

The legendary rock band used Deep Voodoo’s deepfake tech to de-age them in the video for the lead single off upcoming album 'Foreign Tongues.' By Ethan Millman Music Editor In the François ...

Deepfake versions of Mick Jagger, Keith Richards, and Ronnie Wood – all looking like they did about half a century ago – sing their latest single “In the Stars” in a new video for the song directed by ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...